Literature DB >> 8097296

Metabolic manipulation of neural tissue to counter the hypersynchronous excitation of migraine and epilepsy.

A Hamberger1, N M van Gelder.   

Abstract

Very prominent in the large biochemical data bank on epilepsy, is the almost "universal" finding that a familial or environmental predisposition towards epilepsy, as well as the earliest signs preceding other forms of hypersynchronous excitation, coincide with an altered glutamate metabolism. Hence, it has become increasingly apparent that glutamate occupies a central position in the development of epilepsy or in the onset of a migraine incident. The importance of glutamate is explained by a variety of functions in the CNS: as a dominant constituent of many proteins, by its intermediary role in linking energy metabolism to that of many other amino acids, and as the virtually exclusive precursor of GABA. Moreover, glutamate serves as the primary substrate in ammonia detoxification and the product, glutamine, actively participates in CSF water homeostasis. Finally, by its direct electrophysiological and metabolic actions on neurons and glia, via at least four distinct types of receptor proteins, glutamate is implicated in a number of critical mechanisms of information. These include neuronal excitatory modulation, intracellular Ca2+ redistribution, and key metabolic (phosphorylation) mechanisms. The phenomena, when exaggerated due to excessive extracellular glutamate levels, may cause pathological effects such as hypersynchrony--epilepsy, Spreading Depression-migraine, high internal Ca(2+)--damage, impaired phosphorylation/dephosphorylation-necrosis, among others. Not surprising therefore that severe epilepsy may eventually cause CNS cytoarchitectural and metabolic damage, or conversely, that neural tissue trauma not infrequently gives rise to epilepsy many years later. Both conditions are associated with a persistent, excessive leakage or release of glutamate into the extracellular milieu. An electrophysiological and neurochemical commonality between migraine and epilepsy has also been noted.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097296     DOI: 10.1007/bf00967254

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  12 in total

1.  Astrocyte heterogeneity: endogenous amino acid levels and release evoked by non-N-methyl-D-aspartate receptor agonists and by potassium-induced swelling in type-1 and type-2 astrocytes.

Authors:  G Levi; M Patrizio
Journal:  J Neurochem       Date:  1992-05       Impact factor: 5.372

Review 2.  Neuronal damage and epilepsy: basic and clinical interface.

Authors:  R S Fisher
Journal:  Epilepsy Res       Date:  1991-10       Impact factor: 3.045

Review 3.  Neuronal discharge hypersynchrony and the intracranial water balance in relation to glutamic acid and taurine redistribution: migraine and epilepsy.

Authors:  N M van Gelder
Journal:  Prog Clin Biol Res       Date:  1990

Review 4.  The regulation and modulation of pH in the nervous system.

Authors:  M Chesler
Journal:  Prog Neurobiol       Date:  1990       Impact factor: 11.685

5.  The hyperexcited brain: glutamic acid release and failure of inhibition.

Authors:  N M van Gelder
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

Review 6.  Glutamate and the pathophysiology of hypoxic--ischemic brain damage.

Authors:  S M Rothman; J W Olney
Journal:  Ann Neurol       Date:  1986-02       Impact factor: 10.422

7.  Transmitter glutamate release from isolated nerve terminals: evidence for biphasic release and triggering by localized Ca2+.

Authors:  H T McMahon; D G Nicholls
Journal:  J Neurochem       Date:  1991-01       Impact factor: 5.372

8.  Glucocorticoids exacerbate kainic acid-induced extracellular accumulation of excitatory amino acids in the rat hippocampus.

Authors:  B A Stein-Behrens; E M Elliott; C A Miller; J W Schilling; R Newcombe; R M Sapolsky
Journal:  J Neurochem       Date:  1992-05       Impact factor: 5.372

9.  The effect of L-carnitine-supplemented total parenteral nutrition on tissue amino acid concentrations in piglets.

Authors:  H Böhles; D Michalk; U Brandl; W Fekl; H C Börresen; K Stehr
Journal:  J Nutr       Date:  1984-04       Impact factor: 4.798

10.  Glutamate metabolism in rat cortical astrocyte cultures.

Authors:  S E Farinelli; W J Nicklas
Journal:  J Neurochem       Date:  1992-05       Impact factor: 5.372

View more
  7 in total

1.  Nico M. van Gelder, the inquisitive neurochemist.

Authors:  A Hamberger; T A Reader
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

2.  Modulatory effects of activation of metabotropic glutamate receptors on GABAergic circuits in the mouse cortex.

Authors:  Tingting Liu; Iraklis Petrof; S Murray Sherman
Journal:  J Neurophysiol       Date:  2014-03-12       Impact factor: 2.714

3.  Synthesis and characterization of N,N-dichlorinated amino acids: taurine, homotaurine, GABA and L-leucine.

Authors:  N M van Gelder; R J Bowers
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

Review 4.  Metabolic parameters of epilepsy: adjuncts to established antiepileptic drug therapy.

Authors:  Nico M van Gelder; Allan L Sherwin
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

Review 5.  Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate.

Authors:  Mikael Angehagen; Elinor Ben-Menachem; Lars Rönnbäck; Elisabeth Hansson
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

6.  Assessing the Effect of Zinc Supplementation on the Frequency of Migraine Attack, Duration, Severity, Lipid Profile and hs-CRP in Adult Women.

Authors:  Monireh Mazaheri; Arash Mosarrezaii Aghdam; Mohammad Heidari; Rasoul Zarrin
Journal:  Clin Nutr Res       Date:  2021-04-27

7.  2D MR Spectroscopy Combined with Prior-Knowledge Fitting Is Sensitive to HCV-Associated Cerebral Metabolic Abnormalities.

Authors:  Rajakumar Nagarajan; Manoj K Sarma; April D Thames; Steven A Castellon; Charles H Hinkin; M Albert Thomas
Journal:  Int J Hepatol       Date:  2012-07-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.